IRIS Accounts Production v24.3.2.46 15274402 Board of Directors 14.11.23 31.3.24 31.3.24 0 false true false false true false Ordinary Shares 0.01000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh152744022023-11-13152744022024-03-31152744022023-11-142024-03-31152744022023-11-1315274402ns15:EnglandWales2023-11-142024-03-3115274402ns14:PoundSterling2023-11-142024-03-3115274402ns10:Director12023-11-142024-03-3115274402ns10:PrivateLimitedCompanyLtd2023-11-142024-03-3115274402ns10:SmallEntities2023-11-142024-03-3115274402ns10:AuditExempt-NoAccountantsReport2023-11-142024-03-3115274402ns10:SmallCompaniesRegimeForDirectorsReport2023-11-142024-03-3115274402ns10:SmallCompaniesRegimeForAccounts2023-11-142024-03-3115274402ns10:FullAccounts2023-11-142024-03-3115274402ns10:OrdinaryShareClass12023-11-142024-03-3115274402ns10:Director22023-11-142024-03-3115274402ns10:RegisteredOffice2023-11-142024-03-3115274402ns5:CurrentFinancialInstruments2024-03-3115274402ns5:ShareCapital2024-03-3115274402ns5:FurtherSpecificReserve1ComponentTotalEquity2024-03-3115274402ns5:RetainedEarningsAccumulatedLosses2024-03-3115274402ns5:AdditionsToInvestments2024-03-3115274402ns5:CostValuation2024-03-3115274402ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3115274402ns10:OrdinaryShareClass12024-03-31
REGISTERED NUMBER: 15274402 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE PERIOD 14 NOVEMBER 2023 TO 31 MARCH 2024

FOR

ALPHA BIOLABORATORIES HOLDINGS LIMITED

ALPHA BIOLABORATORIES HOLDINGS LIMITED (REGISTERED NUMBER: 15274402)

CONTENTS OF THE FINANCIAL STATEMENTS
for the Period 14 November 2023 to 31 March 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


ALPHA BIOLABORATORIES HOLDINGS LIMITED

COMPANY INFORMATION
for the Period 14 November 2023 to 31 March 2024







DIRECTORS: Ms R Thomas
Mr D Thomas





REGISTERED OFFICE: 14 Webster Court,
Carina Park
Warrington
Cheshire
WA5 8WD





REGISTERED NUMBER: 15274402 (England and Wales)





ACCOUNTANTS: Xeinadin
100 Barbirolli Square
Manchester
M2 3BD

ALPHA BIOLABORATORIES HOLDINGS LIMITED (REGISTERED NUMBER: 15274402)

BALANCE SHEET
31 March 2024

Notes £    £   
FIXED ASSETS
Investments 4 4,195,206

CURRENT ASSETS
Debtors 5 4

CREDITORS
Amounts falling due within one year 6 2,500
NET CURRENT LIABILITIES (2,496 )
TOTAL ASSETS LESS CURRENT LIABILITIES 4,192,710

CAPITAL AND RESERVES
Called up share capital 7 306
Merger relief reserve 4,194,904
Retained earnings (2,500 )
SHAREHOLDERS' FUNDS 4,192,710

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 3 March 2025 and were signed on its behalf by:





Mr D Thomas - Director


ALPHA BIOLABORATORIES HOLDINGS LIMITED (REGISTERED NUMBER: 15274402)

NOTES TO THE FINANCIAL STATEMENTS
for the Period 14 November 2023 to 31 March 2024


1. STATUTORY INFORMATION

Alpha Biolaboratories Holdings Limited is a private company, limited by share capital, incorporated in England and Wales, registration number 15274402. The address of the registered office and principal place of business is Unit 14 Webster Court, Carina Park, Westbrook, Warrington, WA5 8WD.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Preparation of consolidated financial statements
The financial statements contain information about Alpha Biolaboratories Holdings Limited as an individual company and do not contain consolidated financial information as the parent of a group. The company is exempt under Section 399(2A) of the Companies Act 2006 from the requirements to prepare consolidated financial statements.

Related party exemption
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Other debtors
Other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method, less impairment losses for bad and doubtful debts except where the effect of discounting would be immaterial. In such cases, the receivables are stated at cost less impairment for bad and doubtful debts.

Merger relief reserve
The Merger Relief Reserve arose in relation to the acquisition of the ordinary share capital of the companies detailed in Note 4. The reserve represents the excess of the fair value of the shares issued over their nominal value. This reserve is non-distributable and will remain in equity unless and until it is realised, either through the disposal of the acquired entity or through a qualifying transaction that allows for its transfer to retained earnings.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was NIL.

4. FIXED ASSET INVESTMENTS
Shares in
group
undertakings
£   
COST
Additions 4,195,206
At 31 March 2024 4,195,206
NET BOOK VALUE
At 31 March 2024 4,195,206

ALPHA BIOLABORATORIES HOLDINGS LIMITED (REGISTERED NUMBER: 15274402)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Period 14 November 2023 to 31 March 2024


4. FIXED ASSET INVESTMENTS - continued

The following subsidiary undertakings were acquired in the period:


Name
Class of
Shares

Holding

Principal Activity

Alpha Biolaboratories Legal Ltd Ordinary 100% Sale and supply of toxicology and DNA services
Alpha Biolaboratories Analytical Ltd Ordinary 100% Provision of laboratory testing services
Alpha Biolaboratories Retail Ltd Ordinary 100% Sale and supply of toxicology and DNA services
Alpha Biolaboratories Ltd Ordinary 100% Sale and supply of toxicology and DNA services

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Other debtors 4

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Amounts owed to group undertakings 2,500

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal
value: £   
30,600 Ordinary Shares 0.01 306

8. ULTIMATE CONTROLLING PARTY

The ultimate controlling party are the directors of the business by virtue of their controlling interest in the business.